FIGURE 4.

Use of common (A) first‐line, (B) second‐line, and (C) third‐line regimens by year. Abbreviations: FOLFIRI, 5‐fluorouracil + leucovorin + non‐liposomal irinotecan; FOLFIRINOX, 5‐fluorouracil + leucovorin + non‐liposomal irinotecan + oxaliplatin; FOLFOX, 5‐fluorouracil +leucovorin + oxaliplatin; gem/nab, gemcitabine + nanoparticle albumin‐bound paclitaxel.^aIncludes any unique, single chemotherapeutic agent or combination of agents other than those listed by name or acronym above. A full list of regimens is available in the Supporting Information